140 related articles for article (PubMed ID: 10942238)
1. Improved assessment of minimal residual disease in B cell malignancies using fluorogenic consensus probes for real-time quantitative PCR.
Brüggemann M; Droese J; Bolz I; Lüth P; Pott C; von Neuhoff N; Scheuering U; Kneba M
Leukemia; 2000 Aug; 14(8):1419-25. PubMed ID: 10942238
[TBL] [Abstract][Full Text] [Related]
2. Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia.
Verhagen OJ; Willemse MJ; Breunis WB; Wijkhuijs AJ; Jacobs DC; Joosten SA; van Wering ER; van Dongen JJ; van der Schoot CE
Leukemia; 2000 Aug; 14(8):1426-35. PubMed ID: 10942239
[TBL] [Abstract][Full Text] [Related]
3. [Assessment of minimal residual disease in adult patients with B-lineage acute lymphoblastic leukemia using rearranged immunoglobulin loci detection].
Yao L; Chen ZX; Cen JN; Liu H; He J; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2010 Jul; 31(7):433-7. PubMed ID: 21122394
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of minimal residual disease detection using four-color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantation.
Böttcher S; Ritgen M; Pott C; Brüggemann M; Raff T; Stilgenbauer S; Döhner H; Dreger P; Kneba M
Leukemia; 2004 Oct; 18(10):1637-45. PubMed ID: 15343348
[TBL] [Abstract][Full Text] [Related]
5. MRD detection in B-cell non-Hodgkin lymphomas using Ig gene rearrangements and chromosomal translocations as targets for real-time quantitative PCR.
Pott C; Brüggemann M; Ritgen M; van der Velden VH; van Dongen JJ; Kneba M
Methods Mol Biol; 2013; 971():175-200. PubMed ID: 23296964
[TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of minimal residual disease in childhood lymphoid malignancies using an allele-specific oligonucleotide real-time quantitative polymerase chain reaction.
Tarusawa M; Yashima A; Endo M; Maesawa C
Int J Hematol; 2002 Feb; 75(2):166-73. PubMed ID: 11939263
[TBL] [Abstract][Full Text] [Related]
7. The use of IgH fingerprinting and ASO-dependent PCR for the investigation of residual disease (MRD) in ALL.
Chim JC; Coyle LA; Yaxley JC; Cole-Sinclair MF; Cannell PK; Hoffbrand VA; Foroni L
Br J Haematol; 1996 Jan; 92(1):104-15. PubMed ID: 8562380
[TBL] [Abstract][Full Text] [Related]
8. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes.
Pongers-Willemse MJ; Verhagen OJ; Tibbe GJ; Wijkhuijs AJ; de Haas V; Roovers E; van der Schoot CE; van Dongen JJ
Leukemia; 1998 Dec; 12(12):2006-14. PubMed ID: 9844931
[TBL] [Abstract][Full Text] [Related]
9. Touch-down reverse transcriptase-PCR detection of IgV(H) rearrangement and Sybr-Green-based real-time RT-PCR quantitation of minimal residual disease in patients with chronic lymphocytic leukemia.
Peková S; Marková J; Pajer P; Dvorák M; Cetkovský P; Schwarz J
Mol Diagn; 2005; 9(1):23-34. PubMed ID: 16035732
[TBL] [Abstract][Full Text] [Related]
10. Use of UITma DNA polymerase improves the PCR detection of rearranged immunoglobulin heavy chain CDR3 junctions.
Linke B; Bolz I; Pott C; Hiddemann W; Kneba M
Leukemia; 1995 Dec; 9(12):2133-7. PubMed ID: 8609729
[TBL] [Abstract][Full Text] [Related]
11. MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCR.
Pott C; Brüggemann M; Ritgen M; van der Velden VHJ; van Dongen JJM; Kneba M
Methods Mol Biol; 2019; 1956():199-228. PubMed ID: 30779036
[TBL] [Abstract][Full Text] [Related]
12. Consensus JH gene probes with conjugated 3'-minor groove binder for monitoring minimal residual disease in acute lymphoblastic leukemia.
Uchiyama M; Maesawa C; Yashima-Abo A; Tarusawa M; Endo M; Sugawara W; Chida S; Onodera S; Tsukushi Y; Ishida Y; Tsuchiya S; Masuda T
J Mol Diagn; 2005 Feb; 7(1):121-6. PubMed ID: 15681483
[TBL] [Abstract][Full Text] [Related]
13. Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology.
Nakao M; Janssen JW; Flohr T; Bartram CR
Cancer Res; 2000 Jun; 60(12):3281-9. PubMed ID: 10866322
[TBL] [Abstract][Full Text] [Related]
14. [Dynamic monitoring of minimal residual disease in acute lymphoid leukemia].
Shan SL; Xing HY; Tian Z; Tang KJ; Rao Q; Wang M; Wang JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1404-8. PubMed ID: 22169292
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of contaminating tumor cells in autologous peripheral blood stem cells of B-cell non-Hodgkin lymphomas using immunoglobulin heavy chain gene allele-specific oligonucleotide real-time quantitative-polymerase chain reaction.
Yashima A; Maesawa C; Uchiyama M; Tarusawa M; Satoh T; Satoh M; Enomoto S; Sugawara K; Numaoka H; Murai K; Utsugisawa T; Ishida Y; Masuda T
Leuk Res; 2003 Oct; 27(10):925-34. PubMed ID: 12860013
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin heavy-chain consensus probes for real-time PCR quantification of residual disease in acute lymphoblastic leukemia.
Donovan JW; Ladetto M; Zou G; Neuberg D; Poor C; Bowers D; Gribben JG
Blood; 2000 Apr; 95(8):2651-8. PubMed ID: 10753847
[TBL] [Abstract][Full Text] [Related]
17. Detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin hypervariable region specific oligonucleotide probes.
Jonsson OG; Kitchens RL; Scott FC; Smith RG
Blood; 1990 Nov; 76(10):2072-9. PubMed ID: 2122920
[TBL] [Abstract][Full Text] [Related]
18. Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.
van der Velden VH; Hochhaus A; Cazzaniga G; Szczepanski T; Gabert J; van Dongen JJ
Leukemia; 2003 Jun; 17(6):1013-34. PubMed ID: 12764363
[TBL] [Abstract][Full Text] [Related]
19. Automated high resolution PCR fragment analysis for identification of clonally rearranged immunoglobulin heavy chain genes.
Linke B; Bolz I; Fayyazi A; von Hofen M; Pott C; Bertram J; Hiddemann W; Kneba M
Leukemia; 1997 Jul; 11(7):1055-62. PubMed ID: 9204991
[TBL] [Abstract][Full Text] [Related]
20. Structure of Bcl-1 and IgH-CDR3 rearrangements as clonal markers in mantle cell lymphomas.
Pott C; Tiemann M; Linke B; Ott MM; von Hofen M; Bolz I; Hiddemann W; Parwaresch R; Kneba M
Leukemia; 1998 Oct; 12(10):1630-7. PubMed ID: 9766510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
